Invention Grant
- Patent Title: Nanoparticle complexes of paclitaxel, trastuzumab, and albumin
-
Application No.: US15052623Application Date: 2016-02-24
-
Publication No.: US10406224B2Publication Date: 2019-09-10
- Inventor: Svetomir N. Markovic , Wendy K. Nevala
- Applicant: Mayo Foundation for Medical Education and Research
- Applicant Address: US MN Rochester
- Assignee: Mayo Foundation for Medical Education and Research
- Current Assignee: Mayo Foundation for Medical Education and Research
- Current Assignee Address: US MN Rochester
- Agency: Myers Bigel, P.A.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/32 ; A61K45/06 ; A61K31/337 ; C07K16/22 ; C07K16/28 ; A61K33/24 ; A61K31/555 ; A61K9/00 ; A61K9/51 ; A61K41/00 ; C07K16/30 ; A61K47/69 ; A61K47/68 ; A61K31/282 ; A61K47/64 ; A61K9/14 ; B82Y5/00 ; A61K39/00
Abstract:
Described are stable nanoparticle complexes of 100 nm to 900 nm comprising paclitaxel, albumin and an antibody. The nanoparticle complexes are suitable for the treatment of cancer.
Public/Granted literature
- US20160235860A1 Cancer Treatments Public/Granted day:2016-08-18
Information query
